Prevalence of Aspirin Use among Type ۲ Diabetic Patients in Iran
محل انتشار: مجله دیابت و چاقی ایران، دوره: 5، شماره: 4
سال انتشار: 1392
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 70
فایل این مقاله در 5 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJDO-5-4_006
تاریخ نمایه سازی: 16 آبان 1402
چکیده مقاله:
Abstract
Objective: Patients with type ۲ diabetes mellitus (DM) have a markedly increased risk of cardiovascular morbidity and mortality. There are some recommendations for prescription of aspirin in these patients. Our purpose was to determine aspirin usage rate in diabetic patients and to compare it in different ages and based upon cardiovascular disease (CVD) risk factors.
Materials and Methods: In this study we collected data from ۱۲۵۶ self-reported diabetes mellitus patients referred to Yazd Diabetes Research Center during ۲۰۱۰-۲۰۱۱. This data included age, sex, history of diabetes mellitus, drug history, antiplatelet therapy duration, smoking, hypertension, dyslipidemia, family history of premature CVD and albuminuria.
Results: ۴۸.۵% of patients were male (۶۰۹ patients) and ۵۱.۵% were female (۶۴۷ patients). From female patients ≤۶۰ years old, ۵۲.۷% used antiplatelet drug however, this percent for patients over ۶۰ years was ۵۸.۹% and for male patients ≤۵۰ and >۵۰ was ۴۷.۷% and ۸۱%, respectively. From antiplatelet drug users, ۴۳.۱% of males aged ≤۵۰ and ۲۹.۲% of females aged ≤۶۰ years old had no or one risk factor that is unnecessary to take it.
Conclusion: Physician must encourage diabetic patients to use aspirin when the potential benefit of a reduction in cardiovascular disease outweighs the potential harms. So, clinical judgment is required for prescription of aspirin in men aged ≤ ۵۰ years and women aged ≤ ۶۰ years without multiple risk factors.
کلیدواژه ها:
نویسندگان
Akram Ghadiri-Anari
Yazd Diabetes Research Center, Shahid Sadoughi University of Medical Science, Yazd, Iran
Amir Hossein Jafari-Mehdiabad
Yazd Diabetes Research Center, Shahid Sadoughi University of Medical Science, Yazd, Iran
Mohammad Afkhami-Ardekani
Yazd Diabetes Research Center, Shahid Sadoughi University of Medical Science, Yazd, Iran
Mahboobeh Rezapour
Yazd Diabetes Research Center, Shahid Sadoughi University of Medical Science, Yazd, Iran
Fahimeh Chavoshzadeh-Tafti
Yazd Diabetes Research Center, Shahid Sadoughi University of Medical Science, Yazd, Iran